DNTH: Dianthus Therapeutics Inc Kompaniya qiymatining sof foydaga nisbati
Noyob patologiyalar sohasidagi patent ustunligi uchun kurash yuqori noaniqlikni yuzaga keltirmoqda, shunga qaramay, GURU.Markets grafigidagi Dianthus Therapeutics (DNTH) kompaniyasining P/E koeffitsiyenti biznesning yashovchanligiga bo'lgan bozor bahosini ko'rsatadi, bunda qiymat -25.80 darajasida mustahkamlandi. FDA ning qat'iy nazorati va kapital talab qiluvchi R&D tadqiqotlari ushbu barqarorlikni tasdiqlaydi, joriy daromadlar esa komplement tizimlarini ishlab chiqish bo'yicha hamkorlik grantlariga asoslangan.
%20P%2FE%20multiplikatori&width=1200&height=400&colorIndex=0&v=mwhdatcg.m7-7dqbc3k&start=20220704&end=20261115&filename=GURU_Markets_-_DNTH_-_Dianthus-Therapeutics_-_PE-Multiple "DNTH: Dianthus Therapeutics Biznesning o‘zini qoplash muddati 21.02.2024 - 15.11.2026 | 👁️GURU.Markets👁️")
Dianthus Corp (DNTH) kompaniyasining tahliliy kesimlari
- narx va narxlar bo'yicha konsensus prognoz:
- bozor kapitallashuvi haqida ma'lumot:
- buxgalteriya balansi bo'yicha sof aktivlar qiymati ko'rsatkichlari:
- qarzlar va to'lov qobiliyati haqida ma'lumot:
Umumiy qarzning xususiy kapitalga nisbati Dianthus Therapeutics|DNTH - Uzoq muddatli qarzning o'z kapitaliga nisbati|Qisqa muddatli qarzning kapitalga nisbati dianthustx.com|DNTH - Kompaniya qarzlari|Qarzning balans qiymatiga nisbati Dianthus Therapeutics Inc|DNTH - Kompaniyaning uzoq muddatli qarzlari|Qisqa muddatli qarz Dianthus Therapeutics|Shoshilinch likvidlik koeffitsiyenti dianthustx.com
- foyda va bozor multiplikatorlari tafsilotlari:
DNTH - Sof foyda|Kompaniya foydasi prognozi Dianthus Therapeutics|DNTH - P/E multiplikatori|Forvard P/E multiplikatori Dianthus Corp|DNTH - Narxning foydaga va o‘sish sur’atiga nisbati|Korxona qiymatining amortizatsiyadan oldingi operatsion foydaga nisbati Dianthus Corp|DNTH - Eskirish chegirilmasdan oldingi operatsion foyda|So'nggi to'rtta chorak uchun bir aksiya uchun foyda Dianthus Therapeutics|DNTH - Bir aksiya uchun sof foyda (EPS TTM)|So'nggi 12 oy davomida bitta aksiya uchun foydaning yillik o'sishi dianthustx.com|DNTH - Bu yil bir aksiya uchun sof foyda o'sishi|Keyingi yil uchun foyda o'sishi prognozi Dianthus Therapeutics
- realizatsiya hajmi va tushum ko'rsatkichlari:
Kompaniyaning har tomonlama tahlili:Dianthus Therapeutics, Inc. DNTH
Dianthus Therapeutics (DNTH) uchun, u yerda yosh jamoa erta bosqichdagi klinik dasturlarni rivojlantirmoqda, foyda ko'rsatkichiga nisbatan narx dinamikasi biotexnologiya sindikatining kelgusidagi muvaffaqiyatiga bo'lgan bozor kutuvlarini aks ettiradi. Bozor kapitalizatsiyasining sof foydaga nisbati sifatida hisoblanadigan ushbu koeffitsient investorlarga o'sish potentsiali uchun to'langan premiumni baholash imkonini beradi, bu esa cho'qqi nuqtalarda hissiyotlarga berilib sotib olishdan qochishga va qiymatlar haddan tashqari past bo'lganda stagnatsiya xavfini anglashga yordam beradi.
Muhim raqobatchilar
P/E multiplikatori Argenx|Narx-foyda koeffitsiyenti BNTX (BioNTech Group)|ABVX (abivax.com) - Kompaniya qiymatining sof foydaga nisbati|P/E multiplikatori ADMA (admabiologics.com)|Biznesning o‘zini qoplash muddati protagonist-inc.com (PTGX)|IMVT - Narxning foydaga nisbati|Kiniksa Pharmaceuticals, Ltd. (KNSA) - Narx-foyda koeffitsiyenti|Grifols Biemat (GRFS) - Narxning foydaga nisbati|Narx-foyda koeffitsiyenti Adaptive Biotechnologies|Narx-foyda koeffitsiyenti CLDX|P/E multiplikatori auriniapharma.com|Narxning foydaga nisbati BioCryst Pharmaceuticals Inc (BCRX)|Vera Therapeutics - Narx-foyda multiplikatori|P/E multiplikatori PHVS (pharvaris.com)|AbCellera Bio (ABCL) - Kapitalizatsiyaning foydaga nisbati|TRML: Narx-foyda koeffitsiyenti|Kapitalizatsiyaning sof foydaga nisbati PGEN|PHAR: P/E multiplikatori|Kapitalizatsiyaning foydaga nisbati Nektar Therapeutics Inc (NKTR)|Narx-foyda koeffitsiyenti UPB|Narx-foyda multiplikatori ZBIO (Zenas Biopharma, Inc.)|Narx-foyda koeffitsiyenti IMNM (Immunome Bio)|Biznesning o‘zini qoplash muddati Gossamer Bio, Inc.|P/E multiplikatori KALV (KalVista Pharma)|Septerna, Inc. (SEPN) - Kapitalizatsiyaning foydaga nisbati|PVLA - Narxning foydaga nisbati|SVRA - P/E multiplikatori|Rigel Pharmaceuticals Inc (RIGL) - Narxning foydaga nisbati|ANAB - Biznesning o‘zini qoplash muddati|Narx-foyda koeffitsiyenti ATXS|ENGN: Kompaniya qiymatining sof foydaga nisbati|Narxning foydaga nisbati RAPT Therapeutics (RAPT)|JBIO (Aerovate) - Kompaniya qiymatining sof foydaga nisbati|P/E multiplikatori ACRS (Aclaris Therapeutics)|Kompaniya qiymatining sof foydaga nisbati KYTX|Tiziana Life Sciences - P/E multiplikatori|CABA: Narxning foydaga nisbati|VTYX: P/E multiplikatori|THTX (Theratechnologies, Inc) - Narxning foydaga nisbati|AVTX (Avalo Therapeutics, Inc.) - P/E multiplikatori|P/E multiplikatori Eledon Pharmaceuticals|Narxning foydaga nisbati Agenus Inc. (AGEN)|Narx-foyda koeffitsiyenti Climb Bio Inc. CLYM|P/E multiplikatori ZURA (Zura Bio Ltd)|ATYR - Narx-foyda koeffitsiyenti|ADAG - Narxning foydaga nisbati|IMA - P/E multiplikatori|STTK: P/E multiplikatori|Equillium Bio (EQ) - P/E multiplikatori|CNTB (connectbiopharm.com) - P/E multiplikatori|IMUX: Kompaniya qiymatining sof foydaga nisbati|P/E multiplikatori ATRA|P/E multiplikatori InflaRx NV (IFRX)|X4 Pharmaceuticals, Inc. (XFOR) - Kapitalizatsiyaning sof foydaga nisbati|P/E multiplikatori adicetbio.com ACET|Celularity - P/E multiplikatori|Kompaniya qiymatining sof foydaga nisbati INMB (INmune Bio Corp)|BRNS (Barinthus Bio) - Narx-foyda koeffitsiyenti|Kapitalizatsiyaning sof foydaga nisbati KZR (Kezar Life Sciences)|Narxning foydaga nisbati SAB Biotherapeutics Inc.|Akari Therapeutics Plc - Kapitalizatsiyaning sof foydaga nisbati|Narx-foyda koeffitsiyenti ENLV (Enlivex Therapeutics Ltd.)|Narx-foyda koeffitsiyenti Q32 Bio Inc QTTB|Narxning foydaga nisbati geovax.com GOVX|P/E multiplikatori edesabiotech.com EDSA|iBio Corporation - P/E multiplikatori|Kompaniya qiymatining sof foydaga nisbati CARM (carismatx.com)|XTL Biopharmaceuticals Ltd. (XTLB) - Narxning foydaga nisbati|Bolt Bio (BOLT) - P/E multiplikatori|HCWB (HCW Biologics Inc) - P/E multiplikatori|Narx-foyda koeffitsiyenti Aptevo Therapeutics (APVO)|P/E multiplikatori AIM|Bozor narxining sof foydaga nisbati ADTX|P/E multiplikatori GRI (GRI Bio Corporation)|P/E multiplikatori XORTX Corp XRTX|HIND - Narxning foydaga nisbati|Revelation Biosciences (REVB) - Narx-foyda koeffitsiyenti|INDP (Indaptus Therapeutics, Inc.) - Narx-foyda koeffitsiyenti|Scinai Immunotherapeutics Ltd (SCNI) - P/E multiplikatori|CALI (CalciMedica Inc) - P/E multiplikatori|affimed.com - Kapitalizatsiyaning sof foydaga nisbati|Narxning foydaga nisbati allakos.com (ALLK)|P/E multiplikatori HOOKIPA Pharma, Inc. (HOOK)|IGM Biosciences Inc. - Narx-foyda koeffitsiyenti|iTeos Therapeutics, Inc. (ITOS) - Kapitalizatsiyaning foydaga nisbati|OCEA: Narx-foyda koeffitsiyenti|Kompaniya qiymatining sof foydaga nisbati TCBP (TC BioPharm (Holdings) PLC)|THRD: P/E multiplikatori
